INAB
IN8bio, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:10 PM EDT
1.39USD-0.714%(-0.01)39,473
Pre-marketOct 2, 2026 8:53:30 AM EDT
1.46USD+4.286%(+0.06)
Loading…
Loading…
13.70M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$1.40
Beta
1.48
52-Week High
$2.73 2026-01-16
52-Week Low
$0.88 2026-08-12
SMA 50
$1.12
SMA 200
$1.54
Avg. Vol 10D
61,083
Avg. Vol 30D
47,603
Avg. Vol 90D
56,337
Relative Vol
0.83
9.86M
7.21M
73.15%
63,110
0.88%
2.21
40%/60%
35.52%
31.31%
2.0400%
200,000
607
607
Nov 5, 2026 (31d)
Jun 6, 2025 · 1-for-30 (reverse)
Sep 24, 2026
IN8bio at Sidoti Small-Cap Virtual Conference: gamma-delta push · 
Investing.com
Sep 22, 2026
IN8bio to Present at Sidoti Small-Cap Virtual Conference · 
GlobeNewswire Inc.
INAB Profile
in8bio, inc. ("in8bio") is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta t cells. we are developing a broad portfolio of programs and are the first company to advance genetically modified gamma-delta t cells into the clinic.
INAB Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.24 | 2026-09-28 | +12.10% | -3.540 |
| 1M | 1.20 | 2026-09-04 | +15.83% | 0.921 |
| 3M | 1.44 | 2026-07-06 | -3.47% | 0.697 |
| 6M | 1.41 | 2026-04-06 | -1.42% | 0.732 |
| 1Y | 2.39 | 2025-10-03 | -41.84% | 1.483 |
| 2Y | 7.90 | 2024-10-04 | -82.40% | — |
| 5Y | 212.40 | 2021-10-04 | -99.35% | 0.464 |
INAB Stock Summary
IN8bio, Inc. Common Stock (NASDAQ:INAB) stock price today is $1.39, and today's volume is 39,473. INAB is down 0.714% today. The 30 day average volume is 47,603. INAB market cap is $13.70M with 9.86M shares outstanding.